About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD3.50
- USD3.63
- USD3.43
- USD6.89
- -5.30%
- 5M
- 19.07k
- 93M
- 3.10
- -46.30%
Stock News
1 hour ago
Market Snapshot: Stock futures struggle to make headway as traders turn attention to jobs data
MarketWatch
1 hour ago
Nvidia CEO feels safe relying on Taiwan for chips
Reuters
2 hours ago
Seymourpowell, Leading Design Agency, Chooses Box for Cloud Content Management
Yahoo
3 hours ago
This Company Keeps Hospitals Clean. Why It’s Time to Buy the Stock.
Yahoo
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
